The prevalence of infectious diseases and epidemics has provided an important impetus to the growth of the India molecular diagnostics market, as these diseases require molecular diagnostic testing. The occurrence of H1N1 (swine flu) has resulted in a speedy augment in clinical laboratories opting for facility upgrades for molecular testing. The common infectious diseases which are most prevalent among the people of India include tuberculosis, HIV, Hepatitis B (HBV), Hepatitis C (HCV) and Human Papillomavirus (HPV).

“The molecular diagnostics testing systems enable precise detection of various infectious diseases which include HIV, HBV and HCV. The combination of infectious disease immunoassay and molecular testing offers a complete solution for diagnosis and monitoring of HIV and hepatitis.” – According to the research report ‘India Genomics and Molecular Diagnostics Market Prospects to 2018 - Driven by Automation and Introduction of New Technologies’ by Ken Research.

Infectious diseases have remained one of the major concerns for public health in India. Diagnosis of viral diseases is very crucial since it necessitates identification of specific antibodies produced by the immune system. The demand for accurate diagnosis and tests for HBV and HCV has led to the growth of virology segment in the molecular diagnostics market in the country. The emergence of molecular diagnostics in India has helped the physicians to diagnose the diseases and provide effective treatment for the chronic infectious diseases.

The growing prevalence of infectious diseases in the country is likely to spur the demand for molecular diagnostics based virology tests in the near future. Growth in the forthcoming years will also be driven by rapid technology developments. With the introduction of latest markers for identifying, selecting and diagnosing specific conditions, market prospects will proliferate.

The report provides detailed overview on the molecular diagnostics market in India and help reader to identify the ongoing trends in the key segments of the industry and anticipated growth in future depending upon changing industry dynamics in coming years. The report will aid industry consultants, molecular diagnostics manufacturing companies and marketing companies and other stakeholders to align their market centric strategies according to ongoing and expected trends in future.


Download sample report here- www.kenresearch.com/sample-report-on-India+Genomics+and+Molecular+Diagnostics+Market

Browse report with TOC- http://www.kenresearch.com/healthcare/trial-diagnostic-services/india-genomics-molecular-diagnostics-market-research-report/524-91.html

Contact Person- Ankur Gupta
Contact Email Id- [email protected]